ALBO

Albireo Pharma, Inc. Common Stock
ALBO

Overview Fund Activity
Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

24 hedge funds and large institutions have $50M invested in Albireo Pharma, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Holders
24
Holders Change
+7
Holders Change %
+41.18%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
4
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PA
1
Perceptive Advisors
New York
$17.4M
2
BBA
2
Baker Bros. Advisors
New York
$4.12M
3
SAM
3
Sectoral Asset Management
Quebec, Canada
$3.89M
4
SFM
4
Sphera Funds Management
Israel
$2.13M
5
Millennium Management
5
Millennium Management
New York
$618K

Top Sellers

1
OM
1
Opaleye Management
Massachusetts
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$3M
3
SCM
3
Segantii Capital Management
Hong Kong
$0
4
CG
4
Cutler Group
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
$0 1 -244 -100%
Wells Fargo
27
Wells Fargo
California
– – -8 Closed
Creative Planning
28
Creative Planning
Kansas
$0 5 – –
1
2